256 related articles for article (PubMed ID: 36188580)
1. Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders.
Hong H; Lu X; Lu Q; Huang C; Cui Z
Front Pharmacol; 2022; 13():1015035. PubMed ID: 36188580
[TBL] [Abstract][Full Text] [Related]
2. Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice.
Qiu J; Yan Z; Tao K; Li Y; Li Y; Li J; Dong Y; Feng D; Chen H
J Neuroinflammation; 2016 Oct; 13(1):263. PubMed ID: 27724964
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models.
Li J; Xiang H; Huang C; Lu J
Front Pharmacol; 2021; 12():797298. PubMed ID: 34975495
[TBL] [Abstract][Full Text] [Related]
4. The pro-apoptosis effect of sinomenine in renal carcinoma via inducing autophagy through inactivating PI3K/AKT/mTOR pathway.
Deng F; Ma YX; Liang L; Zhang P; Feng J
Biomed Pharmacother; 2018 Jan; 97():1269-1274. PubMed ID: 29145153
[TBL] [Abstract][Full Text] [Related]
5. Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αB-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model.
Zhang Y; Chen Y; Wu J; Manaenko A; Yang P; Tang J; Fu W; Zhang JH
Stroke; 2015 Sep; 46(9):2637-46. PubMed ID: 26251254
[TBL] [Abstract][Full Text] [Related]
6. A review for the pharmacological effect of lycopene in central nervous system disorders.
Chen D; Huang C; Chen Z
Biomed Pharmacother; 2019 Mar; 111():791-801. PubMed ID: 30616078
[TBL] [Abstract][Full Text] [Related]
7. Sinomenine Attenuates Traumatic Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation via Nrf2 Pathway.
Zhang L; Zhang W; Zheng B; Tian N
Neurochem Res; 2019 Apr; 44(4):763-775. PubMed ID: 30603983
[TBL] [Abstract][Full Text] [Related]
8. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin.
Shao W; Zhang SZ; Tang M; Zhang XH; Zhou Z; Yin YQ; Zhou QB; Huang YY; Liu YJ; Wawrousek E; Chen T; Li SB; Xu M; Zhou JN; Hu G; Zhou JW
Nature; 2013 Feb; 494(7435):90-4. PubMed ID: 23242137
[TBL] [Abstract][Full Text] [Related]
9. From mundane to classic: Sinomenine as a multi-therapeutic agent.
Li D; Zhong Z; Ko CN; Tian T; Yang C
Br J Pharmacol; 2023 Oct; ():. PubMed ID: 37846470
[TBL] [Abstract][Full Text] [Related]
10. A review for the pharmacological effects of paeoniflorin in the nervous system.
Hong H; Lu X; Wu C; Chen J; Chen C; Zhang J; Huang C; Cui Z
Front Pharmacol; 2022; 13():898955. PubMed ID: 36046834
[TBL] [Abstract][Full Text] [Related]
11. Sinomenine inhibits amyloid beta-induced astrocyte activation and protects neurons against indirect toxicity.
Singh D; Agrawal A; Singal CMS; Pandey HS; Seth P; Sharma SK
Mol Brain; 2020 Mar; 13(1):30. PubMed ID: 32127013
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum.
Yamasaki H
Acta Med Okayama; 1976 Feb; 30(1):1-20. PubMed ID: 61710
[TBL] [Abstract][Full Text] [Related]
13. Sinomenine Attenuates Trimethyltin-Induced Cognitive Decline via Targeting Hippocampal Oxidative Stress and Neuroinflammation.
Rostami A; Taleahmad F; Haddadzadeh-Niri N; Joneidi E; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
J Mol Neurosci; 2022 Aug; 72(8):1609-1621. PubMed ID: 35543800
[TBL] [Abstract][Full Text] [Related]
14. Sinomenine relieves oxygen and glucose deprivation-induced microglial activation via inhibition of the SP1/miRNA-183-5p/IκB-α signaling pathway.
Qin F; Zhao Y; Shang W; Zhao ZM; Qian X; Zhang BB; Cai H
Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):140-147. PubMed ID: 30084807
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of anthocyanins and its major component cyanidin-3-O-glucoside (C3G) in the central nervous system: An outlined review.
Zhang J; Wu J; Liu F; Tong L; Chen Z; Chen J; He H; Xu R; Ma Y; Huang C
Eur J Pharmacol; 2019 Sep; 858():172500. PubMed ID: 31238064
[TBL] [Abstract][Full Text] [Related]
16. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury.
Sharma R; Kambhampati SP; Zhang Z; Sharma A; Chen S; Duh EI; Kannan S; Tso MOM; Kannan RM
J Control Release; 2020 Jul; 323():361-375. PubMed ID: 32339548
[TBL] [Abstract][Full Text] [Related]
17. Sinomenine, an Alkaloid Derived from
Yoo JH; Ha TW; Hong JT; Oh KW
Biomol Ther (Seoul); 2017 Nov; 25(6):586-592. PubMed ID: 29081090
[No Abstract] [Full Text] [Related]
18. The antidepressant-like effects of sinomenine in mice: a behavioral and neurobiological characterization.
Li X; Liu C; Jiang B; Chen K; Li W; Wang H
Behav Pharmacol; 2018 Jun; 29(4):306-315. PubMed ID: 29035920
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory Effects of
Kim TW; Han JM; Han YK; Chung H
Int J Med Sci; 2018; 15(8):758-764. PubMed ID: 30008584
[TBL] [Abstract][Full Text] [Related]
20. Anti-allodynic effects of N-demethylsinomenine, an active metabolite of sinomenine, in a mouse model of postoperative pain.
Ou Y; Su M; Ling Y; Wei Q; Pan F; Li J; Li JX; Zhu Q
Eur J Pharmacol; 2018 Mar; 823():105-109. PubMed ID: 29408089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
